The Ensign Group, Inc. (ENSG)
USD 136.41
(-2.56%)
USD 136.41
(-2.56%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.87 Billion USD | 18.88% |
| 2022 | 1.57 Billion USD | 24.4% |
| 2021 | 1.26 Billion USD | 13.58% |
| 2020 | 1.11 Billion USD | -17.29% |
| 2019 | 1.34 Billion USD | 453.72% |
| 2018 | 243.24 Million USD | -22.27% |
| 2017 | 312.92 Million USD | 10.34% |
| 2016 | 283.61 Million USD | 184.55% |
| 2015 | 99.67 Million USD | 45.74% |
| 2014 | 68.39 Million USD | -73.63% |
| 2013 | 259.3 Million USD | 24.85% |
| 2012 | 207.69 Million USD | 10.55% |
| 2011 | 187.87 Million USD | 31.83% |
| 2010 | 142.5 Million USD | 30.18% |
| 2009 | 109.46 Million USD | 80.78% |
| 2008 | 60.55 Million USD | -4.75% |
| 2007 | 63.57 Million USD | -1.48% |
| 2006 | 64.52 Million USD | 147.67% |
| 2005 | 26.05 Million USD | 0.0% |
| 2003 | 16.23 Million USD | 35.11% |
| 2002 | 12.01 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.93 Billion USD | 3.46% |
| 2024 Q3 | 146.62 Million USD | 3.12% |
| 2024 Q2 | 1.95 Billion USD | 1.08% |
| 2023 Q4 | 1.87 Billion USD | -0.95% |
| 2023 FY | 1.87 Billion USD | 18.88% |
| 2023 Q1 | 1.9 Billion USD | 21.13% |
| 2023 Q2 | 1.88 Billion USD | -0.99% |
| 2023 Q3 | 1.88 Billion USD | 0.08% |
| 2022 Q1 | 1.42 Billion USD | 12.28% |
| 2022 Q3 | 1.47 Billion USD | 3.12% |
| 2022 FY | 1.57 Billion USD | 24.4% |
| 2022 Q2 | 1.43 Billion USD | 0.66% |
| 2022 Q4 | 1.57 Billion USD | 6.73% |
| 2021 Q1 | 1.13 Billion USD | 2.19% |
| 2021 FY | 1.26 Billion USD | 13.58% |
| 2021 Q2 | 1.2 Billion USD | 5.46% |
| 2021 Q3 | 1.28 Billion USD | 7.4% |
| 2021 Q4 | 1.26 Billion USD | -1.87% |
| 2020 Q1 | 1.36 Billion USD | 1.25% |
| 2020 Q4 | 1.11 Billion USD | -0.23% |
| 2020 Q2 | 1.15 Billion USD | -15.49% |
| 2020 Q3 | 1.11 Billion USD | -3.11% |
| 2020 FY | 1.11 Billion USD | -17.29% |
| 2019 Q2 | 1.32 Billion USD | 4.24% |
| 2019 Q3 | 1.31 Billion USD | -1.13% |
| 2019 Q4 | 1.34 Billion USD | 2.72% |
| 2019 FY | 1.34 Billion USD | 453.72% |
| 2019 Q1 | 1.27 Billion USD | 423.01% |
| 2018 Q3 | 255.68 Million USD | -8.07% |
| 2018 Q4 | 243.24 Million USD | -4.87% |
| 2018 Q2 | 278.12 Million USD | -4.25% |
| 2018 FY | 243.24 Million USD | -22.27% |
| 2018 Q1 | 290.48 Million USD | -7.17% |
| 2017 Q1 | 266.63 Million USD | -5.99% |
| 2017 Q4 | 312.92 Million USD | 5.85% |
| 2017 Q3 | 295.62 Million USD | 1.02% |
| 2017 Q2 | 292.63 Million USD | 9.75% |
| 2017 FY | 312.92 Million USD | 10.34% |
| 2016 Q3 | 170.61 Million USD | -7.45% |
| 2016 FY | 283.61 Million USD | 184.55% |
| 2016 Q4 | 283.61 Million USD | 66.23% |
| 2016 Q2 | 184.35 Million USD | 26.04% |
| 2016 Q1 | 146.26 Million USD | 46.75% |
| 2015 Q4 | 99.67 Million USD | 42.75% |
| 2015 Q3 | 69.82 Million USD | 41.0% |
| 2015 Q2 | 49.52 Million USD | 1372.49% |
| 2015 Q1 | 3.36 Million USD | -95.08% |
| 2015 FY | 99.67 Million USD | 45.74% |
| 2014 FY | 68.39 Million USD | -73.63% |
| 2014 Q2 | - USD | -100.0% |
| 2014 Q3 | 3.41 Million USD | 0.0% |
| 2014 Q4 | 68.39 Million USD | 1901.46% |
| 2014 Q1 | 257.48 Million USD | -0.7% |
| 2013 Q1 | 205.92 Million USD | -0.85% |
| 2013 Q4 | 259.3 Million USD | 22.08% |
| 2013 Q2 | 214.17 Million USD | 4.0% |
| 2013 Q3 | 212.4 Million USD | -0.83% |
| 2013 FY | 259.3 Million USD | 24.85% |
| 2012 Q3 | 199.43 Million USD | -0.85% |
| 2012 Q1 | 202.85 Million USD | 7.98% |
| 2012 Q2 | 201.14 Million USD | -0.84% |
| 2012 Q4 | 207.69 Million USD | 4.14% |
| 2012 FY | 207.69 Million USD | 10.55% |
| 2011 Q1 | 141.82 Million USD | -0.48% |
| 2011 FY | 187.87 Million USD | 31.83% |
| 2011 Q4 | 187.87 Million USD | 7.72% |
| 2011 Q3 | 174.4 Million USD | 24.44% |
| 2011 Q2 | 140.15 Million USD | -1.18% |
| 2010 Q2 | 108.48 Million USD | -0.43% |
| 2010 Q4 | 142.5 Million USD | 31.94% |
| 2010 Q3 | 108.01 Million USD | -0.44% |
| 2010 FY | 142.5 Million USD | 30.18% |
| 2010 Q1 | 108.95 Million USD | -0.47% |
| 2009 Q4 | 109.46 Million USD | 83.19% |
| 2009 Q3 | 59.75 Million USD | -0.44% |
| 2009 Q2 | 60.01 Million USD | -0.43% |
| 2009 FY | 109.46 Million USD | 80.78% |
| 2009 Q1 | 60.27 Million USD | -0.45% |
| 2008 Q2 | 61.05 Million USD | -3.56% |
| 2008 FY | 60.55 Million USD | -4.75% |
| 2008 Q4 | 60.55 Million USD | -0.45% |
| 2008 Q3 | 60.82 Million USD | -0.38% |
| 2008 Q1 | 63.3 Million USD | -0.41% |
| 2007 Q1 | 64.27 Million USD | -0.4% |
| 2007 Q3 | 63.82 Million USD | -0.27% |
| 2007 FY | 63.57 Million USD | -1.48% |
| 2007 Q4 | 63.57 Million USD | -0.41% |
| 2007 Q2 | 64 Million USD | -0.42% |
| 2006 FY | 64.52 Million USD | 147.67% |
| 2006 Q4 | 64.52 Million USD | 0.0% |
| 2005 Q4 | 26.05 Million USD | 0.0% |
| 2005 FY | 26.05 Million USD | 0.0% |
| 2003 FY | 16.23 Million USD | 35.11% |
| 2002 FY | 12.01 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | -23.867% |
| Addus HomeCare Corporation | 175.18 Million USD | -968.203% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -1777.532% |
| Amedisys, Inc. | 487.21 Million USD | -284.082% |
| American Oncology Network, Inc. | 128.32 Million USD | -1358.25% |
| Astrana Health, Inc. | 321.01 Million USD | -482.934% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | -24.82% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -1529.044% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -17074.136% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -35428.745% |
| COMPASS Pathways plc | 33.04 Million USD | -5562.024% |
| DocGo Inc. | 46.49 Million USD | -3924.546% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -4188.528% |
| InnovAge Holding Corp. | 113.03 Million USD | -1555.504% |
| Assure Holdings Corp. | 14.8 Million USD | -12539.642% |
| The Joint Corp. | 16.73 Million USD | -11082.06% |
| LifeStance Health Group, Inc. | 511.04 Million USD | -266.173% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -284667.163% |
| ModivCare Inc. | 1.14 Billion USD | -64.139% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -562606.997% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -41748.074% |
| Option Care Health, Inc. | 1.16 Billion USD | -60.432% |
| P3 Health Partners Inc. | 124.64 Million USD | -1401.351% |
| P3 Health Partners Inc. | 124.64 Million USD | -1401.351% |
| The Pennant Group, Inc. | 329.63 Million USD | -467.693% |
| Surgery Partners, Inc. | 3.06 Billion USD | 38.878% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -754142.794% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -1461.824% |
| The Oncology Institute, Inc. | 119.81 Million USD | -1461.824% |